Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. NKE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. ANET
10. BE

Go back to Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Axsome Therapeutics (AXSM) PT Raised to $302 at RBC Capital

May 4, 2026 4:07 PM EDT

RBC Capital analyst Leonid Timashev raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $302.00 (from $242.00) while maintaining a Outperform rating.

The analyst comments "Today, AXSM reported 1Q26 earnings, and we had a chance to catch up with mgmt. Auvelity in... More